In this episode, sponsored by Thermo Fisher Scientific, we’re taking a look at how genomic technologies are transforming cancer care – now and in the future, and the importance of making sure that these advances are available to all.
We look at what the future looks like for both adult and childhood cancers, as well as exploring how important fast genetic testing is to patients and how new technology could help.
- Greg Simon, past president of the Biden Cancer Initiative and former executive director of the White House Cancer Moonshot Task Force.
- Jim Downing – president and CEO of St Jude Children’s Research Hospital
- Dr Marianne Grantham, Head of Cytogenetics and Molecular Haematology department at the Royal London Hospital
- Kim Wood, Thermo Fisher Scientific’s Clinical Sequencing Division
If you’re a cancer researcher or cytogeneticist looking to use next generation sequencing in your work, fill in this simple form for more information about ThermoFisher’s next generation sequencing solutions.
Follow us on Twitter – @geneticsunzip